Eric Warren

Insider Reports History

Location
Ann Arbor, MI
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Warren:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Chief Commercial Officer Common Stock 370K $362K $0.98 17 Apr 2025 Direct
Esperion Therapeutics, Inc. Chief Commercial Officer Stock Option (right to buy) 191K $309K $1.62 14 Mar 2025 Direct

Insider Reports Filed by Eric Warren

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ESPR Esperion Therapeutics, Inc. 17 Apr 2025 1 -$106 4 Chief Commercial Officer 21 Apr 2025, 16:04
ESPR Esperion Therapeutics, Inc. 18 Mar 2025 1 -$3.62K 4 Chief Commercial Officer 19 Mar 2025, 16:02
ESPR Esperion Therapeutics, Inc. 14 Mar 2025 2 $0 4 Chief Commercial Officer 17 Mar 2025, 17:16
ESPR Esperion Therapeutics, Inc. 19 Feb 2025 1 -$446 4 Chief Commercial Officer 20 Feb 2025, 16:50
ESPR Esperion Therapeutics, Inc. 17 Jan 2025 1 -$278 4 Chief Commercial Officer 21 Jan 2025, 16:37
ESPR Esperion Therapeutics, Inc. 17 Dec 2024 1 -$5.43K 4 Chief Commercial Officer 18 Dec 2024, 16:13
ESPR Esperion Therapeutics, Inc. 19 Nov 2024 1 -$427 4 Chief Commercial Officer 20 Nov 2024, 16:10
ESPR Esperion Therapeutics, Inc. 17 Oct 2024 1 -$227 4 Chief Commercial Officer 18 Oct 2024, 16:08
ESPR Esperion Therapeutics, Inc. 17 Sep 2024 1 -$4.65K 4 Chief Commercial Officer 18 Sep 2024, 16:11
ESPR Esperion Therapeutics, Inc. 19 Aug 2024 1 -$411 4 Chief Commercial Officer 20 Aug 2024, 16:03
ESPR Esperion Therapeutics, Inc. 17 Jul 2024 1 -$279 4 Chief Commercial Officer 19 Jul 2024, 08:30
ESPR Esperion Therapeutics, Inc. 18 Jun 2024 1 -$7.25K 4 Chief Commercial Officer 20 Jun 2024, 16:16
ESPR Esperion Therapeutics, Inc. 17 May 2024 1 -$477 4 Chief Commercial Officer 20 May 2024, 16:14
ESPR Esperion Therapeutics, Inc. 14 Mar 2024 2 $0 4 Chief Commercial Officer 15 Mar 2024, 16:35
ESPR Esperion Therapeutics, Inc. 20 Sep 2023 1 -$924 4 Chief Commercial Officer 21 Sep 2023, 18:06
ESPR Esperion Therapeutics, Inc. 18 Aug 2023 1 -$344 4 Chief Commercial Officer 21 Aug 2023, 17:32
ESPR Esperion Therapeutics, Inc. 19 Jul 2023 1 -$168 4 Chief Commercial Officer 20 Jul 2023, 16:38
ESPR Esperion Therapeutics, Inc. 21 Jun 2023 1 -$894 4 Chief Commercial Officer 22 Jun 2023, 16:45
ESPR Esperion Therapeutics, Inc. 17 May 2023 1 -$356 4 Chief Commercial Officer 18 May 2023, 16:07
ESPR Esperion Therapeutics, Inc. 19 Apr 2023 1 -$147 4 Chief Commercial Officer 20 Apr 2023, 16:12
ESPR Esperion Therapeutics, Inc. 17 Mar 2023 1 -$937 4 Chief Commercial Officer 20 Mar 2023, 16:16
ESPR Esperion Therapeutics, Inc. 14 Mar 2023 2 $0 4 Chief Commercial Officer 15 Mar 2023, 09:22
ESPR Esperion Therapeutics, Inc. 07 Mar 2023 1 -$25.7K 4 Chief Commercial Officer 08 Mar 2023, 15:22
ESPR Esperion Therapeutics, Inc. 18 Oct 2022 1 -$823 4 Chief Commercial Officer 19 Oct 2022, 16:11
ESPR Esperion Therapeutics, Inc. 19 Sep 2022 1 -$1.76K 4 Chief Commercial Officer 20 Sep 2022, 16:09
ESPR Esperion Therapeutics, Inc. 31 Aug 2022 1 $7.46K 4 Chief Commercial Officer 31 Aug 2022, 16:14
ESPR Esperion Therapeutics, Inc. 17 Aug 2022 1 -$1.36K 4 Chief Commercial Officer 18 Aug 2022, 16:10
ESPR Esperion Therapeutics, Inc. 19 Jul 2022 1 -$2.84K 4 Chief Commercial Officer 20 Jul 2022, 16:27
ESPR Esperion Therapeutics, Inc. 17 Jun 2022 1 -$1.25K 4 Chief Commercial Officer 21 Jun 2022, 16:06
ESPR Esperion Therapeutics, Inc. 07 Jun 2022 1 $0 4 Chief Commercial Officer 09 Jun 2022, 16:46
ESPR Esperion Therapeutics, Inc. 17 May 2022 1 -$1.17K 4 Chief Commercial Officer 18 May 2022, 16:30
ESPR Esperion Therapeutics, Inc. 14 Mar 2022 1 $0 4 Chief Commercial Officer 16 Mar 2022, 17:11
ESPR Esperion Therapeutics, Inc. 01 Mar 2022 0 $0 3 Chief Commercial Officer 09 Mar 2022, 15:53